SYMLIN� Market OpportunityUnited States

Source: ADA, CDC, Amylin internal data for 2001

TOTAL Diabetes US: 17.5 million people

~6% growth per year

(3x population growth)

Orals

5.9 M

Not Diagnosed

6.0 M

Insulin

4.5 M

Diet

1.1 M

Previous slide

Next slide

Back to first slide

View graphic version